• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位乳腺癌中c-erbB-2免疫反应性与胸腺嘧啶核苷标记指数之间的关系。

Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.

作者信息

Barnes D M, Meyer J S, Gonzalez J G, Gullick W J, Millis R R

机构信息

ICRF Clinical Oncology Unit, Guy's Hospital, London, UK.

出版信息

Breast Cancer Res Treat. 1991 Mar;18(1):11-7. doi: 10.1007/BF01975438.

DOI:10.1007/BF01975438
PMID:1677296
Abstract

The relationship between the presence of the c-erbB-2 protein, demonstrated immunohistochemically with antibody 21N, and thymidine labelling index (TLI) has been studied in the in situ component of 70 cases of carcinoma of the breast. A significant association was found between high TLI and positive staining. Twenty of the 70 cases stained (29%) and of those that were stained 75% had a high TLI; 43% of those with a high TLI stained positively but only 14% of those with a low TLI stained positively. Strong correlations were seen between nuclear size and histological pattern and both 21N staining and TLI. The majority of carcinomas of comedo pattern with large nuclei were 21N positive and had a high TLI, whilst those with small nuclei and a predominantly cribriform/micropapillary appearance did not stain and had a low TLI. In tumours of mixed histological pattern there was less concordance between staining and TLI. The significance of these findings in relation to the biological behaviour of these tumours and their clinical management is discussed.

摘要

运用抗体21N通过免疫组织化学方法检测了70例乳腺癌原位成分中c-erbB-2蛋白的表达,并研究了其与胸腺嘧啶核苷标记指数(TLI)之间的关系。结果发现高TLI与阳性染色之间存在显著关联。70例中有20例染色阳性(29%),在这些染色阳性的病例中,75%具有高TLI;高TLI病例中有43%染色阳性,而低TLI病例中只有14%染色阳性。核大小与组织学类型以及21N染色和TLI之间均存在强相关性。大多数具有大核的粉刺型癌21N呈阳性且TLI高,而那些具有小核且主要呈筛状/微乳头外观的癌不染色且TLI低。在混合组织学类型的肿瘤中,染色与TLI之间的一致性较差。讨论了这些发现与这些肿瘤生物学行为及其临床管理的相关性。

相似文献

1
Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.原位乳腺癌中c-erbB-2免疫反应性与胸腺嘧啶核苷标记指数之间的关系。
Breast Cancer Res Treat. 1991 Mar;18(1):11-7. doi: 10.1007/BF01975438.
2
Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ.乳腺导管原位癌中c-erbB-2蛋白的免疫组化检测
Hum Pathol. 1990 Nov;21(11):1164-7. doi: 10.1016/0046-8177(90)90154-w.
3
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?c-erbB-2癌蛋白的过表达:为何这种情况在乳腺导管原位癌中比浸润性乳腺癌中更频繁发生,以及这具有预后意义吗?
Eur J Cancer. 1992;28(2-3):644-8. doi: 10.1016/s0959-8049(05)80117-0.
4
An immunohistochemical study of the presence of c-erbB-2 protein in Paget's disease of the nipple.
Histopathology. 1989 Nov;15(5):505-14. doi: 10.1111/j.1365-2559.1989.tb01610.x.
5
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.病理学观点。乳腺导管原位癌:关于一种新的简化组织学分类以及细胞增殖与c-erbB-2蛋白表达之间关联的提议。
Mod Pathol. 1994 Feb;7(2):257-62.
6
Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast.c-erbB-2在女性乳腺原位及相邻浸润性导管腺癌中的表达。
Pathobiology. 1992;60(3):117-21. doi: 10.1159/000163709.
7
c-erbB-2 expression in different histological types of invasive breast carcinoma.c-erbB-2在不同组织学类型浸润性乳腺癌中的表达
J Clin Pathol. 1991 Mar;44(3):211-4. doi: 10.1136/jcp.44.3.211.
8
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
9
Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.乳腺导管原位癌中雌激素受体的表达:与DNA流式细胞术分析及c-erbB-2癌蛋白表达的关系。
Br J Cancer. 1993 Jul;68(1):156-61. doi: 10.1038/bjc.1993.305.
10
Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.
Virchows Arch A Pathol Anat Histopathol. 1992;420(5):433-40. doi: 10.1007/BF01600515.

引用本文的文献

1
Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.粉刺型导管原位癌是基底样乳腺癌的前驱病变:一种新的p63/Her2/neu表达亚组的鉴定。
Oncotarget. 2013 Feb;4(2):231-41. doi: 10.18632/oncotarget.818.
2
Biological features of premalignant disease in the human breast.人类乳腺癌前病变的生物学特征。
J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):351-64. doi: 10.1023/a:1009573710675.
3
A new model for ductal carcinoma in situ suggests strategies for treatment.一种新的原位导管癌模型提出了治疗策略。

本文引用的文献

1
Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.
Lab Invest. 1986 Jan;54(1):41-51.
2
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.人类乳腺癌:HER-2/neu癌基因扩增与复发及生存的相关性。
Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106.
3
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer.标记指数与雌激素受体及肿瘤大小在淋巴结阴性乳腺癌中的预后意义
Breast Cancer Res. 2002;4(5):176-8. doi: 10.1186/bcr447. Epub 2002 Jul 19.
4
Simultaneous Assay of ErbB-2 Protein and Carcinoembryonic Antigen in Cyst Fluid as an Aid in Diagnosing Cystic Lesions of the Breast.同时检测囊液中的ErbB-2蛋白和癌胚抗原以辅助诊断乳腺囊性病变
Breast Cancer. 1994 Jul 30;1(1):25-30. doi: 10.1007/BF02967371.
5
Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.乳腺导管原位癌的细胞学和结构异质性。
J Clin Pathol. 1997 Jul;50(7):596-9. doi: 10.1136/jcp.50.7.596.
6
Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer.乳腺癌中8号染色体拷贝数的荧光原位杂交评估
Breast Cancer Res Treat. 1996;38(2):201-8. doi: 10.1007/BF01806674.
7
Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breast.乳腺导管原位癌中ErbB-2和pS2蛋白的差异分布。
Breast Cancer Res Treat. 1996;37(1):89-92. doi: 10.1007/BF01806635.
8
The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma.化疗对原发性乳腺癌的形态、细胞增殖、细胞凋亡及癌蛋白表达的影响。
Br J Cancer. 1994 Aug;70(2):335-41. doi: 10.1038/bjc.1994.303.
9
Detection of c-erbB-2 gene amplification in nipple discharge by means of polymerase chain reaction.
Breast Cancer Res Treat. 1995;33(1):89-92. doi: 10.1007/BF00666075.
10
c-erbB-3 protein expression in ovarian tumours.c-erbB-3蛋白在卵巢肿瘤中的表达
Br J Cancer. 1995 Apr;71(4):758-62. doi: 10.1038/bjc.1995.147.
Breast Cancer Res Treat. 1986;7(3):161-9. doi: 10.1007/BF01806246.
4
Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.人肿瘤中的胸苷标记指数、流式细胞术S期测量及DNA指数。比较与相关性
Am J Clin Pathol. 1988 May;89(5):586-95. doi: 10.1093/ajcp/89.5.586.
5
Expression of the c-erbB-2 protein in normal and transformed cells.c-erbB-2蛋白在正常细胞和转化细胞中的表达。
Int J Cancer. 1987 Aug 15;40(2):246-54. doi: 10.1002/ijc.2910400221.
6
Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.通过胸腺嘧啶核苷标记法检测乳腺癌的增殖指数:独立于分期、雌激素和孕激素受体的预后价值
Breast Cancer Res Treat. 1988 Oct;12(2):191-204. doi: 10.1007/BF01805940.
7
Cell kinetics of histologic variants of in situ breast carcinoma.原位乳腺癌组织学亚型的细胞动力学
Breast Cancer Res Treat. 1986;7(3):171-80. doi: 10.1007/BF01806247.
8
Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.通过DNA流式细胞术预测淋巴结阴性乳腺癌患者的复发或生存情况。
N Engl J Med. 1989 Mar 9;320(10):627-33. doi: 10.1056/NEJM198903093201003.
9
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.神经蛋白在乳腺癌中的过表达。与粉刺型导管原位癌相关及在II期乳腺癌中的预后价值有限。
N Engl J Med. 1988 Nov 10;319(19):1239-45. doi: 10.1056/NEJM198811103191902.
10
Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.人乳腺癌中c-erbB-2癌蛋白的过表达:免疫组织学评估与基因扩增相关。
Lancet. 1987 Jul 11;2(8550):69-72. doi: 10.1016/s0140-6736(87)92736-x.